ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Trial to assess AstraZeneca’s long-acting COVID-19 antibody therapy
February 10, 2021The ACTIV-3 sub-study will evaluate the safety and efficacy of the AZD7442 synthetic antibody combination in at least 150 participants with mild-to-moderate COVID-19. -
NIH-sponsored trials evaluate monoclonal antibodies for Covid-19 treatment
December 18, 2020The National Institutes of Health (NIH) in the US has announced the initiation of two Phase III clinical trials analysing investigational monoclonal antibodies for treating people hospitalised with moderate Covid-19.
Pharma Sources Insight January 2025
